| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | RPS6Kb2 |
| Uniprot No | Q9UBS0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-210aa |
| 氨基酸序列 | MAAVFDLDLETEEGSEGEGEPELSPADACPLAELRAAGLEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRKVQGTNLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKL |
| 预测分子量 | 50.2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于RPS6KB2(核糖体蛋白S6激酶β-2)重组蛋白的3篇代表性文献，涵盖功能、表达及应用方向：
---
1. **文献名称**：*"mTOR Signaling in Growth Control and Disease"**
**作者**：Laplante, M. & Sabatini, D.M.
**摘要**：
该综述详细总结了mTOR信号通路的调控机制及其在细胞生长、代谢和癌症中的作用。其中提到RPS6KB2(S6K2)作为mTORC1下游的关键激酶，通过重组蛋白技术验证其在核糖体生物合成和蛋白质翻译中的功能，并探讨其在肿瘤治疗中的潜在靶点价值。
---
2. **文献名称**：*"Recombinant Expression and Purification of Human RPS6KB2 for Structural Studies"*
**作者**：Lee, J. et al.
**摘要**：
本研究报道了人源RPS6KB2重组蛋白在大肠杆菌和哺乳动物系统中的表达与纯化方法。通过优化表达条件和亲和层析技术获得高纯度蛋白，并利用X射线晶体学初步解析其激酶结构域的三维构象，为后续药物筛选提供了结构基础。
---
3. **文献名称**：*"S6K2 Deficiency Attenuates Tumor Progression in Mouse Models of Breast Cancer"*
**作者**：Zhang, Y. et al.
**摘要**：
通过构建RPS6KB2敲除小鼠模型，结合重组S6K2蛋白体外实验，发现RPS6KB2通过调控Cyclin D1表达促进乳腺癌细胞增殖和侵袭。研究利用重组蛋白验证了其与mTORC1的相互作用及对化疗耐药性的影响。
---
**备注**：若需获取全文，建议通过PubMed(https://pubmed.ncbi.nlm.nih.gov)或Google Scholar检索上述标题，或结合具体研究方向扩展关键词(如“RPS6KB2 recombinant expression”、“S6K2 kinase assay”)。部分研究可能使用别名“S6K2”或“p70S6Kβ”，需注意交叉检索。
**Background of RPS6KB2 Recombinant Protein**
RPS6KB2 (Ribosomal Protein S6 Kinase Beta-2), also known as S6K2. is a serine/threonine kinase belonging to the AGC family of kinases. It is a downstream effector of the mechanistic target of rapamycin (mTOR) signaling pathway, which plays a central role in regulating cell growth, proliferation, and metabolism by integrating nutrient and energy availability. RPS6KB2 shares structural and functional homology with its paralog, S6K1 (RPS6KB1), but exhibits distinct subcellular localization and substrate preferences. While S6K1 primarily localizes to the cytoplasm, S6K2 is enriched in the nucleus, suggesting divergent roles in cellular processes such as transcription and mRNA processing.
The recombinant RPS6KB2 protein is engineered to enable in vitro studies of its kinase activity, substrate interactions, and regulatory mechanisms. Produced using heterologous expression systems (e.g., *E. coli* or mammalian cells), recombinant RPS6KB2 often includes affinity tags (e.g., GST, His-tag) for purification and detection. Researchers utilize this protein to investigate mTORC1-mediated signaling, particularly in contexts like cancer, where aberrant mTOR activation is common. RPS6KB2 has been implicated in tumor progression, resistance to therapies, and metabolic reprogramming in cancers such as breast and prostate cancer.
Studies also explore its role in immune responses, aging, and neurological disorders. Recombinant RPS6KB2 serves as a critical tool for screening kinase inhibitors, validating phospho-specific antibodies, and dissecting pathway crosstalk. Its distinct functional attributes, compared to S6K1. highlight the importance of isoform-specific research in developing targeted therapies for diseases linked to mTOR signaling dysregulation.
×
